DHR
Danaher Corp (DHR)
Healthcare • NYSE • $171.16-2.56%
- Symbol
- DHR
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Price
- $171.16
- Daily Change
- -2.56%
- Market Cap
- $121.14B
- Trailing P/E
- 33.23
- Forward P/E
- 18.82
- 52W High
- $242.80
- 52W Low
- $170.74
- Analyst Target
- $250.14
- Dividend Yield
- +0.93%
- Beta
- 0.84
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale …
Company websiteResearch DHR on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.